Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation [NA]

View source ↗

Summary

A clinical trial is recruiting to assess THRIVE Well Cancer FDTN/Exercise with creatine supplementation in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Breast Cancer, Breast Cancer Female | NA | Status: RECRUITING